Dyne Therapeutics (DYN) News
NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.50-0.53 (-3.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DYN news summary
We found 5 recent headlines mentioning Dyne Therapeutics (DYN): 1 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, DYN is down 3.31% at $15.50. The most recent story, "Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Dyne Therapeutics headlines
- Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically…GlobeNewswire
- Dyne Therapeutics to Participate in Upcoming Investor ConferenceWALTHAM, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically…GlobeNewswire
- Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights- Biologics License Application (BLA) for z-rostudirsen in exon 51 Duchenne muscular dystrophy (DMD) under priority review by FDA; PDUFA target action date of January 21, 2027 -GlobeNewswire
- Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically…GlobeNewswire
- Oversold Conditions For Dyne Therapeutics (DYN)Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a…Nasdaq